Challenges of implementing fibromyalgia treatment guidelines in current clinical practice
The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
The current diagnostic and treatment pathway for patients with fibromyalgia (FM) is lengthy, complex, and characterized by multiple physician visits with an average 2-year wait until diagnosis. It is clear that effective identification and appropriate treatment of FM remain a challenge in current clinical practice. Ideally, FM management involves a multidisciplinary approach with the preferable patient pathway originating in primary care but supported by a range of health care providers, including referral to specialist care when necessary. After the publication of individual clinical studies, high-quality reviews, and meta-analyses, recently published FM treatment guidelines have transitioned from an expert consensus to an evidence-based approach. Evidence-based guidelines provide a framework for ensuring early diagnosis and timely adoption of appropriate treatment. However, for successful outcomes, FM treatments must adopt a more holistic approach, which addresses more than just pain. Impact on the associated symptoms of fatigue and cognitive problems, sleep and mood disturbances, and lowered functional status are also important in judging the success of FM therapy. Recently published guidelines recommend the adoption of a symptom-based approach to guide pharmacologic treatment. Emerging treatment options for FM may be best differentiated on the basis of their effect on comorbid symptoms that are often associated with pain (e.g. sleep disturbance, mood, fatigue). The current review discusses the most recently published Canadian guidelines and the implications of the recent European League Against Rheumatism (EULAR) recommendations, with a focus on the challenges of implementing these guidelines in current clinical practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wolfe, F., Clauw, D. J., Fitzcharles, M., Goldenberg, D. L., Katz, R. S., Mease, P., Russell, A. S., Russell, I. J., Winfield, J. B., & Yunus, M. B. (2010) · Arthritis Care & Research · doi:10.1002/acr.20140 · Cited by 3,952 · cited 4×
“[1], which may hinder proper diagnosis and treatment.”
BackgroundMethodSelf-citationAn internet survey of 2,596 people with fibromyalgia
Bennett, R. M., Jones, J., Turk, D. C., Russell, I. J., & Matallana, L. (2007) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-8-27 · Cited by 865
Worldwide epidemiology of fibromyalgia
Queiroz, L. P. (2013) · Current Pain and Headache Reports · doi:10.1007/s11916-013-0356-5 · Cited by 826 · cited 1×
“3%,with an increase in prevalencewith age [3].”
Arnold, L. M., Lu, Y., Crofford, L. J., Wohlreich, M., Detke, M. J., Iyengar, S., & Goldstein, D. J. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20485 · Cited by 624
Self-citationArnold, L. M., Rosen, A., Pritchett, Y. L., D'Souza, D. N., Goldstein, D. J., Iyengar, S., & Wernicke, J. F. (2005) · Pain · doi:10.1016/j.pain.2005.06.031 · Cited by 471 · cited 1×
“Similarly, an FM patient with comorbid depression or anxiety may respond to duloxetine or milnacipran, which improve both mood and pain [39,40,45].”
BackgroundSelf-citationFitzcharles, M.-A., Ste-Marie, P. A., Goldenberg, D. L., Pereira, J. X., Abbey, S., Choinière, M., Ko, G., Moulin, D. E., Panopalis, P., Proulx, J., et al. (2013) · Pain Research and Management · doi:10.1155/2013/918216 · Cited by 409
Behavioral Insomnia Therapy for Fibromyalgia Patients: A Randomized Clinical Trial
Edinger, J. D., Wohlgemuth, W. K., Krystal, A. D., & Rice, J. R. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.21.2527 · Cited by 330 · cited 1×
“of exercise and sleep) and sleep hygiene (focus on sleep as a priority with guidance on how to improve sleep) are other nonpharmacologic therapies associated with improved symptoms or function in FM patients [29,30].”
BackgroundA patient survey of the impact of fibromyalgia and the journey to diagnosis
Choy, E., Perrot, S., Leon, T., Kaplan, J., Petersel, D., Ginovker, A., & Kramer, E. (2010) · BMC Health Services Research · doi:10.1186/1472-6963-10-102 · Cited by 305
Carson, J. W., Carson, K. M., Jones, K. D., Bennett, R. M., Wright, C. L., & Mist, S. D. (2010) · Pain · doi:10.1016/j.pain.2010.08.020 · Cited by 284
Comparative Efficacy and Harms of Duloxetine, Milnacipran, and Pregabalin in Fibromyalgia Syndrome
Häuser, W., Petzke, F., & Sommer, C. (2010) · The Journal of Pain · doi:10.1016/j.jpain.2010.01.002 · Cited by 216 · cited 1×
“numerical rating scale as primary endpoints [35–37]; metaanalyses indicated that there were no differences between these agents for 30% pain relief [43].”
Background
Cited by
Andrade, C. P., Zamunér, A. R., Forti, M., Tamburús, N. Y., & Silva, E. (2019) · European Journal of Physical and Rehabilitation Medicine · doi:10.23736/s1973-9087.18.05041-4 · Cited by 58
Catalá, P., Blanco, S., Perez-Calvo, S., Luque-Reca, O., Bedmar, D., & Peñacoba, C. (2021) · Frontiers in Psychology · doi:10.3389/fpsyg.2021.658974 · Cited by 9
“, 2015), and fibromyalgia in particular (Arnold and Clauw, 2017), must be approached from a multidisciplinary perspective that includes professionals from medicine, rehabilitation, physiotherapy, nursing, and psychology, among others (Arnold and Clauw, 2017).”
BackgroundLahat-Birka, N., Boussi-Gross, R., Ben Ari, A., Efrati, S., & Ben-David, S. (2024) · The Clinical Journal of Pain · doi:10.1097/ajp.0000000000001236 · Cited by 5
Metadata
- Authors
- Arnold, L. M., & Clauw, D. J.
- Venue
- Postgraduate Medicine
- Publisher
- Informa UK Limited
- Published
- 2017-06-19
- Volume
- 129
- Issue
- 7
- Pages
- 709-714
- ISSN
- 0032-5481 (ISSN-L)
- 1941-9260
- OpenAlex
- W2620351605
- Cited by
- 71
- References
- 14
- FWCI
- 2.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Challenges of implementing fibromyalgia treatment guidelines in current clinical practice. https://app.cochat.ai/papers/10.1080/00325481.2017.1336417
- The paper
- Arnold, L. M., & Clauw, D. J. (2017). Challenges of implementing fibromyalgia treatment guidelines in current clinical practice. Postgraduate Medicine. https://doi.org/10.1080/00325481.2017.1336417
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.